Novel Oral Anticoagulants in the Management of Polycythemia Vera and Essential Thrombocythemia

Author(s): Vasiliki Karali, Panayiotis Panayiotidis

Journal Name: Cardiovascular & Hematological Agents in Medicinal Chemistry
Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents

Volume 12 , Issue 1 , 2014

Become EABM
Become Reviewer
Call for Editor


Polycythemia vera and essential thrombocythemia comprise myeloproliferative neoplasms, the main characteristic of which is an over-production of bone marrow myeloid lineage cells. The diseases typically involve thrombosis and their treatment, apart from the strictly hematological aspect, involves antithrombotic agents. In this review we aspire to present the possible role of the newly developed oral anticoagulants in the treatment scheme of polycythemia vera and essential thrombocythemia.

Keywords: Essential thrombocythemia, novel oral anticoagulants, polycythemia vera.

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 01 December, 2014
Page: [26 - 28]
Pages: 3
DOI: 10.2174/187152571201141201092923

Article Metrics

PDF: 82